RATIONAL PHARMACOTHERAPY IN TAKOTSUBO CARDIOMYOPATHY
Autor: | S. Marchev, T. Vekov |
---|---|
Rok vydání: | 2012 |
Předmět: |
Cardiac function curve
Inotrope lcsh:Diseases of the circulatory (Cardiovascular) system medicine.medical_specialty кардиомиопатия Такоцубо Cardiomyopathy Hemodynamics RM1-950 Internal medicine medicine Diseases of the circulatory (Cardiovascular) system Rational pharmacotherapy Pharmacology (medical) In patient cardiovascular diseases Thrombus business.industry lcsh:RM1-950 рharmacotherapy medicine.disease Ventricle outflow tract lcsh:Therapeutics. Pharmacology тakotsubo cardiomyopathy lcsh:RC666-701 RC666-701 Anesthesia cardiovascular system Cardiology Therapeutics. Pharmacology фармакотерапия Cardiology and Cardiovascular Medicine business |
Zdroj: | Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 8, Iss 6, Pp 777-780 (2015) |
ISSN: | 2225-3653 1819-6446 |
DOI: | 10.20996/1819-6446-2012-8-6-777-780 |
Popis: | Rational pharmacotherapy in Takotsubo cardiomyopathy is based on clinical picture and data of functional and laboratory investigations of concrete patient. In patients with hypotension and moderate-to-severe left ventricle outflow tract obstruction inotropic agents must not to be used because they can worsen the degree of obstruction. In these patients beta blockers can improve hemodynamics by causing resolution of the obstruction. If intraventricular thrombus is detected, anticoagulation for at least 3 months is recommended. The duration of anticoagulant therapy may be modified depending on the extent of cardiac function recovery and thrombus resolution. For patients without thrombus but with severe left ventricular dysfunction, anticoagulation is recommended until the akinesis or dyskinesis has resolved but not more than 3 months. |
Databáze: | OpenAIRE |
Externí odkaz: |